LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
LFCR on Nasdaq
Shares outstanding
37,253,000
Price per share
$8.18
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
24,334,794
Total reported value
$179,104,808
% of total 13F portfolios
0%
Share change
-52,950
Value change
-$442,656
Number of holders
98
Price from insider filings
$8.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Greenhaven Road Investment Management, L.P. 9.8% +25% $21,045,970 +$7,270,286 3,616,146 +53% Greenhaven Road Investment Management, L.P. 31 Dec 2024
22NW Fund, LP 7.5% -33% $20,768,278 -$9,716,865 2,975,398 -32% 22NW Fund, LP 27 May 2025
BlackRock, Inc. 5.1% +4% $15,541,966 +$536,503 1,899,903 +3.6% BlackRock, Inc. 31 Dec 2025
David Capital Partners, LLC 4.9% $10,493,460 1,803,000 David Capital Partners, LLC 31 Dec 2024

As of 30 Sep 2025, 98 institutional investors reported holding 24,334,794 shares of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR). This represents 65% of the company’s total 37,253,000 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) together control 63% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
WYNNEFIELD CAPITAL INC 13% 4,703,216 0% 21% $34,615,669
Legion Partners Asset Management, LLC 12% 4,461,823 +0.68% 18% $32,839,017
Greenhaven Road Investment Management, L.P. 9.9% 3,694,832 0% 11% $27,193,964
325 CAPITAL LLC 5.8% 2,162,466 0% 4.8% $15,915,750
BlackRock, Inc. 4.9% 1,840,642 -1.8% 0% $13,547,125
VANGUARD GROUP INC 4.4% 1,622,769 +0.8% 0% $11,943,580
GEODE CAPITAL MANAGEMENT, LLC 2.1% 773,629 -0.24% 0% $5,695,500
GRIZZLYROCK CAPITAL, LLC 2% 738,882 +0.59% 4.2% $5,438,172
MORGAN STANLEY 1.9% 709,699 -4.1% 0% $5,223,387
STATE STREET CORP 1.4% 539,284 +1.6% 0% $3,969,130
DCF Advisers, LLC 1.2% 452,000 -2.4% 1.3% $3,326,720
NORTHERN TRUST CORP 0.64% 238,625 -2% 0% $1,756,279
Quinn Opportunity Partners LLC 0.5% 184,481 -8.8% 0.1% $1,357,780
TOCQUEVILLE ASSET MANAGEMENT L.P. 0.41% 151,700 0% 0.02% $1,116,512
Squarepoint Ops LLC 0.41% 150,909 +386% 0% $1,110,690
LPL Financial LLC 0.4% 148,190 0% 0% $1,090,678
MILLENNIUM MANAGEMENT LLC 0.36% 135,205 +100% 0% $995,109
ROYAL BANK OF CANADA 0.33% 122,983 -1.1% 0% $905,000
MARSHALL WACE, LLP 0.31% 114,075 +223% 0% $839,592
UBS Group AG 0.25% 92,828 -4% 0% $683,214
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.24% 87,687 -0% 0% $645,376
Bank of New York Mellon Corp 0.23% 84,863 +2.2% 0% $624,592
GAMCO INVESTORS, INC. ET AL 0.23% 84,500 0% 0.01% $621,920
CITADEL ADVISORS LLC 0.18% 66,752 +127% 0% $491,295
JANE STREET GROUP, LLC 0.18% 66,272 0% $487,762

Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 22,979 $187,880 -$120,056 $8.18 7
2025 Q3 24,334,794 $179,104,808 -$442,656 $7.36 98
2025 Q2 24,384,958 $198,008,217 +$13,339,391 $8.12 84
2025 Q1 22,755,067 $160,201,705 -$2,326,304 $7.04 85
2024 Q4 23,042,098 $171,205,121 +$31,378,303 $7.43 74
2024 Q3 18,933,619 $93,343,737 +$964,617 $4.93 80
2024 Q2 18,597,383 $95,407,584 -$5,969,880 $5.13 74
2024 Q1 21,527,122 $114,309,004 +$1,264,597 $5.31 76
2023 Q4 0 $0 -$278,546 $8.18 0
2023 Q3 17,649,982 $132,309,917 -$4,239,737 $7.54 67
2023 Q2 17,960,139 $173,672,950 -$21,798,401 $9.67 73
2023 Q1 21,626,729 $81,665,366 -$20,948,145 $3.78 79
2022 Q4 24,684,776 $159,959,234 -$423,334 $6.48 90
2022 Q3 22,936,248 $203,914,634 -$4,231,094 $8.89 81
2022 Q2 24,526,178 $244,520,903 -$5,434,170 $9.97 84
2022 Q1 23,496,437 $272,005,071 -$4,455,513 $11.58 93
2021 Q4 25,273,193 $280,476,179 +$2,975,971 $11.10 93
2021 Q3 25,537,239 $235,451,630 +$6,263,181 $9.22 91
2021 Q2 25,302,162 $284,370,521 -$5,264,027 $11.25 92
2021 Q1 25,853,116 $273,966,016 -$6,654,934 $10.60 91
2020 Q4 26,472,839 $287,225,507 -$2,505,321 $10.85 94
2020 Q3 25,215,539 $245,101,644 +$4,937,490 $9.72 94
2020 Q2 22,993,623 $183,051,082 -$666,936 $7.96 87
2020 Q1 25,179,256 $218,799,542 -$4,613,214 $8.69 83
2019 Q4 27,094,595 $306,434,334 +$284,274 $11.31 92
2019 Q3 26,485,625 $287,483,125 -$10,502,038 $10.87 100
2019 Q2 27,463,169 $257,333,097 +$10,011,493 $9.37 95
2019 Q1 26,312,887 $323,120,159 +$1,994,457 $12.28 90
2018 Q4 25,883,944 $306,456,062 -$191,742 $11.84 88
2018 Q3 25,582,839 $365,661,569 -$3,192,922 $14.40 87
2018 Q2 24,477,028 $364,711,030 -$4,216,374 $14.90 88
2018 Q1 26,312,441 $343,408,751 +$5,884,431 $13.05 86
2017 Q4 25,058,899 $315,548,521 +$374,855 $12.60 86
2017 Q3 25,792,699 $334,007,959 +$6,013,622 $12.95 91
2017 Q2 25,319,851 $375,967,466 +$3,366,609 $14.85 93
2017 Q1 25,084,761 $301,034,568 +$27,008,211 $12.00 80
2016 Q4 24,636,313 $340,004,514 -$4,660,952 $13.80 90
2016 Q3 24,905,769 $333,981,442 -$7,759,312 $13.41 88
2016 Q2 25,547,679 $274,885,218 +$12,840,019 $10.76 89
2016 Q1 25,015,208 $262,661,774 +$7,099,498 $10.50 90
2015 Q4 24,362,954 $288,513,037 +$6,283,614 $11.83 106
2015 Q3 23,756,250 $277,238,057 -$6,496,202 $11.67 109
2015 Q2 23,925,457 $345,238,789 -$137,883 $14.43 106
2015 Q1 24,018,846 $335,003,454 +$729,711 $13.95 96
2014 Q4 24,036,250 $331,952,030 -$1,348,728 $13.81 103
2014 Q3 24,176,903 $294,004,600 +$2,432,526 $12.25 102
2014 Q2 23,880,331 $298,210,311 +$4,410,692 $12.49 98
2014 Q1 23,204,046 $259,105,906 -$9,174,065 $11.16 94